B

Bicycle Therapeutics plc
D

BCYC

20.555
USD
0.28
(1.36%)
مغلق
حجم التداول
10,984
الربح لكل سهم
-3
العائد الربحي
-
P/E
-6
حجم السوق
1,419,240,962
أصول ذات صلة
الأخبار

العنوان: Bicycle Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.